Investors Concerned FDA Changes Could Undermine Medical Device Investments

Ann Arbor -- Michigan venture capitalists are keeping a watchful eye on regulatory changes at the U.S. Food and Drug Administration even as information technology is injecting innovation into the medical device industry.

MORE ON THIS TOPIC